Live from the NIH registry
Studies recruiting near Wilmington right now
Top 25 of 115 recruiting studies, sorted by proximity — each links to its official registry page
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Pregnancy Related
N/A
Observational 20 participants sought
Virtual Research Coordination Center Odevixibat (BYLVAY) Pregnancy Surveillance Program — Wilmington, North Carolina (3.8 mi)
· Sponsor: Ipsen
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Overweight, Obesity
Phase 3
Interventional 285 participants sought
KDCILM, LLC & Accellacare US, Inc. — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Atlantic Prosthetic Services — Wilmington, North Carolina (3.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
Skin Laxity (Submental and Neck), Facial Skin Laxity
N/A
Interventional 273 participants sought
Dermatology — Wilmington, North Carolina (3.8 mi)
· Sponsor: CLASSYS Inc.
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure, Cardiorenal Syndrome
N/A
Interventional 320 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Procyrion
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Novant Health Zimmer Cancer Institute - Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: Regeneron Pharmaceuticals
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE
Hernia
N/A
Interventional 240 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Tissium
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Leland, North Carolina (9.6 mi)
· Sponsor: MoonLake Immunotherapeutics AG
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Hypercholesterolemia
Phase 2
Interventional 420 participants sought
Accellacare of Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: Regeneron Pharmaceuticals
MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib
Tenosynovial Giant Cell Tumor
N/A
Observational 100 participants sought
Synexus Clinical Research, US INC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Deciphera Pharmaceuticals, LLC
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Carolina Arthritis Associates - Cliniverse Research (Network) — Wilmington, North Carolina (3.8 mi)
· Sponsor: Elevara Medicines Limited
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: 89bio, Inc.
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Novant Health Cancer Institute Radiation Oncology - Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
IBD Pregnancy Registry
Inflammatory Bowel Disease (IBD)
N/A
Observational 832 participants sought
PPD — Wilmington, North Carolina (3.8 mi)
· Sponsor: CorEvitas
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Type 2 Diabetes Mellitus
N/A
Interventional 350 participants sought
Accellacare — Wilmington, North Carolina (3.8 mi)
· Sponsor: Insulet Corporation
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Moderate-to-severe Chronic Plaque Psoriasis
Phase 3
Interventional 300 participants sought
Vanda Investigational Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Vanda Pharmaceuticals
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Enveda Therapeutics
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Migraine
N/A
Observational 780 participants sought
Evidera, a PPD business unit — Wilmington, North Carolina (3.8 mi)
· Sponsor: Pfizer
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
Phase 2
Interventional 160 participants sought
Oruka Therapeutics Investigative Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Oruka Therapeutics, Inc.
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Crohn Disease
Phase 2
Interventional 60 participants sought
Innovo Research - Wilmington Gastroenterology Associates — Wilmington, North Carolina (3.8 mi)
· Sponsor: Eli Lilly and Company
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
Osteoarthritis (OA) of the Knee
Phase 2
Interventional 135 participants sought
M3 Wake Research - Wilmington, NC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Pacira Pharmaceuticals, Inc
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma, Cancer
Phase 2
Interventional 50 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center